Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells.

导出 OA

翻译打印收藏纠错

第一作者： Hogyoung,Kim

第一单位： College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA.

作者： Hogyoung,Kim ^[1] ; Emma,Elkins ^[1] ; Rahib,Islam ^[1] ; Bo,Cao ^[1] ; Nour,Abbes ^[1] ; Kaela,Battles ^[1] ; Sihyoung,Kim ^[2] ; Sichan,Kim ^[2] ; Christopher,Williams ^[1]

作者单位： College of Pharmacy, Xavier University of Louisiana, New Orleans, LA 70125, USA. ^[1] College of Arts and Sciences, Xavier University of Louisiana, New Orleans, LA 70125, USA. ^[2]

关键词 CK2 ERα36 HSP90 SERM breast cancer estrogen receptor tamoxifen

DOI 10.3390/cancers16142501

PMID 39061141

发布时间 2025-01-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交